This study tests a drug called AL102 (varegacestat) in people with desmoid tumors that are growing. Desmoid tumors are non-cancerous but can be painful and invasive. The trial has two parts: Part A checks safety and tumor changes, and Part B compares AL102 to a placebo to see if …
Phase: PHASE2, PHASE3 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC